Indeed, a recent study reports that the propeptide domain of pro-NAG-1/GDF15, which remains after the cleavage of mature NAG-1/GDF15, promotes proliferation, invasion, and migration in prostate cancer cell lines when administered as a treatment [21]. This evidence concerns the gene GDF15 and prostate carcinoma.